"10.1371_journal.pone.0057726","plos one","2013-03-19T00:00:00Z","Caroline Ogwang; Muhammed Afolabi; Domtila Kimani; Ya Jankey Jagne; Susanne H Sheehy; Carly M Bliss; Christopher J A Duncan; Katharine A Collins; Miguel A Garcia Knight; Eva Kimani; Nicholas A Anagnostou; Eleanor Berrie; Sarah Moyle; Sarah C Gilbert; Alexandra J Spencer; Peninah Soipei; Jenny Mueller; Joseph Okebe; Stefano Colloca; Riccardo Cortese; Nicola K Viebig; Rachel Roberts; Katherine Gantlett; Alison M Lawrie; Alfredo Nicosia; Egeruan B Imoukhuede; Philip Bejon; Britta C Urban; Katie L Flanagan; Katie J Ewer; Roma Chilengi; Adrian V S Hill; Kalifa Bojang","Kenya Medical Research Institute, Centre for Geographical Medical Research (Coast), Kilifi, Kenya; Medical Research Council Unit, Fajara, The Gambia; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, Churchill Hospital, Oxford, United Kingdom; The Jenner Institute Laboratories, University of Oxford, Old Road Campus Research Building, Oxford, United Kingdom; Clinical Biomanufacturing Facility, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Okairòs AG, Rome, Italy; CEINGE, Naples, Italy; European Vaccine Initiative, Heidelberg, Germany; Department of Molecular Medicine and Medical Biotechnology, University Federico II Naples, Naples, Italy; Liverpool School of Tropical Medicine, Liverpool, United Kingdom","Project management: PS JM NV RR KG AL EI. Conceived and designed the experiments: CO MGK SS CD JM EI PB KF KE R. Chilengi AH KB. Performed the experiments: CO MGK DK YJ CB KC AS JO EK. Analyzed the data: CO MGK DK YJ SS CB KC NA AS PB BU KF KE KB EK. Contributed reagents/materials/analysis tools: EB SM SG SC R. Cortese AN. Wrote the paper: CO MGK SS AH.","AH is a named inventor on the following patent applications on malaria vectored vaccines and immunization regimes (WO2008/122769, Adenoviral vector encoding malaria antigen; and WO 2008/122811 Novel adenovirus vectors). Authors from Okairòs are employees of and/or shareholders in Okairòs, which is developing vectored vaccines for malaria and other diseases. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","03","Caroline Ogwang","CO",33,TRUE,10,9,15,4,TRUE,TRUE,TRUE,2,"2;25",TRUE
